Hospital-acquired Aspergillus fumigatus infection: can molecular typing methods identify an environmental source?

F Symoens1, J Burnod, B Lebeau

  • 1Scientific Institute of Public Health-Louis Pasteur, Mycology Section, Brussels, Belgium. f.symoens@iph.fgov.be

Insights

Identifying the source of Aspergillus fumigatus infections in immunocompromised patients is challenging. Molecular typing revealed significant biodiversity, making hospital acquisition difficult to confirm compared to other Aspergillus species.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Epidemiology

Background:

  • Hospital-acquired Aspergillus fumigatus infections are a concern for immunocompromised patients.
  • Molecular typing methods are expected to identify infection sources.
  • Hospital staff play a key role in infection prevention.

Observation:

  • This study investigated the origins of Aspergillus infection in six hospitalized patients.
  • Clinical, hospital, and home environmental strains of Aspergillus were isolated and analyzed.
  • Sequence-specific DNA primer analysis was used for molecular typing.

Findings:

  • The study confirmed the extensive biodiversity within the Aspergillus fumigatus population.
  • Distinguishing hospital-acquired Aspergillus fumigatus infections from other sources proved difficult.
  • Other Aspergillus species were encountered less frequently than A. fumigatus.

Implications:

  • The findings highlight challenges in attributing Aspergillus fumigatus infections to hospital environments.
  • Accurate source identification is crucial for effective infection control strategies.
  • Further research may be needed to refine molecular typing for Aspergillus species.